Want to see STE full AI Analyst Report?
Revenue by Segment
Shows Steris’s sales split across its business lines—equipment, consumables, and services—revealing which segments drive growth, recurring revenue, and margin strength. Makes it easier to judge how dependent the business is on one‑time equipment sales versus steadier service and consumable income.Steris's Healthcare segment shows robust growth, with recent earnings highlighting a 6% increase in constant currency organic revenue and improved margins due to pricing and productivity gains. The AST segment also demonstrates strong momentum with a 9% revenue growth, despite slight margin pressures from energy and labor costs. Life Sciences benefits from a favorable mix and divestitures, enhancing margins significantly. However, the Dental segment has been phased out, and challenges such as tariff costs and legal settlements could impact future cash flows, despite overall positive sentiment and strategic growth expectations.
Date | Healthcare | AST | Life Sciences | Dental |
|---|---|---|---|---|
Jun 30, 2026 | $1.05B | $297.60M | $146.70M | $0.00 |
Mar 31, 2026 | $1.14B | $289.20M | $162.80M | $0.00 |
Dec 31, 2025 | $1.06B | $286.60M | $145.80M | $0.00 |
Sep 30, 2025 | $1.03B | $281.50M | $145.00M | $0.00 |
Jun 30, 2025 | $974.70M | $281.20M | $135.20M | $0.00 |
Mar 31, 2025 | $1.06B | $273.92M | $149.50M | $0.00 |
Dec 31, 2024 | $976.04M | $258.14M | $136.38M | $0.00 |
Sep 30, 2024 | $944.23M | $256.74M | $127.94M | $0.00 |
Jun 30, 2024 | $901.22M | $249.80M | $128.48M | $0.00 |
Mar 31, 2024 | $1.01B | $250.90M | $160.63M | $0.00 |